Enhertu Injection, Dosage Form : Vial

₹ 1.28 Lakh / Box

Dosage FormVIAL
Active Ingredienttrastuzumab deruxtecan
Brand NameEnhertu 100 MG
Strength100 MG
Supply TypeExporter, Supplier, Distributor
Preferred Buyer Location All over the world

Company Information

Member Since 7 Years
Nature of Business Exporter
GST No. 33ACGPF5198L1ZB

Ask for more detail from the seller

Report incorrect details

Product Details
Company Details

Strength100 MG
Dosage FormVIAL
Active Ingredienttrastuzumab deruxtecan
Number Of FlowerVIAL
Brand NameEnhertu 100 MG
Country of OriginINDIA
COMPANYAstrazeneca
SpecialityMEDICAL ONCOLOGY ANTI CANCER

Enhertu, also known as fam-trastuzumab deruxtecan-nxki (US) or trastuzumab deruxtecan (outside the US), is a HER2-directed antibody-drug conjugate (ADC) jointly developed and commercialized by Daiichi Sankyo. It is a targeted cancer medicine that delivers chemotherapy to cancer cells via a linker attached to a monoclonal antibody. Enhertu is approved in the US and other countries for various HER2-positive cancers, including breast and gastric cancers.